1. Home
  2. IGD vs TMCI Comparison

IGD vs TMCI Comparison

Compare IGD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGD
  • TMCI
  • Stock Information
  • Founded
  • IGD N/A
  • TMCI 2014
  • Country
  • IGD United States
  • TMCI United States
  • Employees
  • IGD N/A
  • TMCI N/A
  • Industry
  • IGD Trusts Except Educational Religious and Charitable
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • IGD Finance
  • TMCI Health Care
  • Exchange
  • IGD Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • IGD 472.4M
  • TMCI 449.2M
  • IPO Year
  • IGD N/A
  • TMCI 2021
  • Fundamental
  • Price
  • IGD $5.98
  • TMCI $7.22
  • Analyst Decision
  • IGD
  • TMCI Hold
  • Analyst Count
  • IGD 0
  • TMCI 5
  • Target Price
  • IGD N/A
  • TMCI $8.60
  • AVG Volume (30 Days)
  • IGD 215.3K
  • TMCI 353.2K
  • Earning Date
  • IGD 01-01-0001
  • TMCI 11-04-2025
  • Dividend Yield
  • IGD 9.15%
  • TMCI N/A
  • EPS Growth
  • IGD N/A
  • TMCI N/A
  • EPS
  • IGD N/A
  • TMCI N/A
  • Revenue
  • IGD N/A
  • TMCI $213,751,000.00
  • Revenue This Year
  • IGD N/A
  • TMCI $10.63
  • Revenue Next Year
  • IGD N/A
  • TMCI $9.44
  • P/E Ratio
  • IGD N/A
  • TMCI N/A
  • Revenue Growth
  • IGD N/A
  • TMCI 7.67
  • 52 Week Low
  • IGD $4.60
  • TMCI $4.54
  • 52 Week High
  • IGD $5.26
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • IGD 64.65
  • TMCI 55.39
  • Support Level
  • IGD $5.86
  • TMCI $6.93
  • Resistance Level
  • IGD $5.93
  • TMCI $7.48
  • Average True Range (ATR)
  • IGD 0.04
  • TMCI 0.32
  • MACD
  • IGD 0.00
  • TMCI -0.06
  • Stochastic Oscillator
  • IGD 80.00
  • TMCI 34.32

About IGD Voya Global Equity Dividend and Premium Opportunity Fund

Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: